Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NISCH | Q9Y2I1 | 5/20 | 0.48 |
| ▸ | MAOB | P27338 | 11/20 | 0.47 |
| ▸ | MAOA | P21397 | 8/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | CASP1 | P29466 | 1/20 | 0.45 |
| ▸ | CASP7 | P55210 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.43 |
| ▸ | TOP2A | P11388 | 2/20 | 0.43 |
| ▸ | TOP2B | Q02880 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8214278 | 0.80 | ALDH1A1 (0.65) | NISCHMAOBMAOAALDH1A1CYP1A2 | |
| SCHEMBL1794747 | 0.80 | TOP2A (0.61) | NISCHMAOBMAOAALDH1A1CYP1A2 | |
| SCHEMBL8201663 | 0.80 | CYP1A2 (0.52) | NISCHMAOBMAOAALDH1A1CYP1A2 | |
| Hydrochloric Acid SCHEMBL1795721 | 0.79 | TOP2A (0.62) | NISCHMAOBMAOAALDH1A1CYP1A2 | |
| SCHEMBL8201404 | 0.77 | NISCH (0.56) | NISCHMAOBMAOAALDH1A1CYP1A2 | |
| SCHEMBL1796041 | 0.77 | NISCH (0.56) | NISCHMAOBMAOAALDH1A1CYP1A2 | |
| SCHEMBL8211455 | 0.77 | NISCH (0.65) | NISCHMAOBMAOAALDH1A1CYP1A2 | |
| Hydrochloric Acid SCHEMBL1796884 | 0.76 | NISCH (0.55) | NISCHMAOBMAOAALDH1A1CYP1A2 | |
| SCHEMBL8188588 | 0.74 | LMNA (0.63) | NISCHMAOBMAOAALDH1A1CYP1A2 | |
| SCHEMBL1795198 | 0.74 | NISCH (0.56) | NISCHMAOBMAOAALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2000078726-A1 | IMIDAZOLINE DERIVATIVES FOR THE TREATMENT OF DIABETES, ESPECIALLY TYPE II DIABETES | ELI LILLY AND COMPANY (US) | 2000-12-28 | — | — | WO | disclosed |